Position in RPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$184,867,169
-$12,463,640 QoQ
Shares Held
3,853,808
-24.5% QoQ
Ownership
0.669%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026VICTORY CAPITAL MANAGEMENT INC holds $2,018,555,898 across 156 Biotechnology names. RPRX ranks #2 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,888,521 | $843,300,167 | |
| 2 | RPRX |
Royalty Pharma plc
This page
|
3,853,808 | $184,867,169 | |
| 3 | INCY |
Incyte Corp
|
1,742,870 | $164,038,924 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
129,074 | $99,727,735 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,937 | $64,829,675 | |
| 6 | INSM |
INSMED Inc
|
396,245 | $64,793,982 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
303,224 | $60,538,671 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
256,598 | $48,509,851 |
All Filings in RPRX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $184,867,169 | 3,853,808 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $197,330,809 | 5,106,905 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $164,313,318 | 4,657,407 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $161,835,230 | 4,491,680 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $112,788,161 | 3,623,134 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $24,954,162 | 978,211 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $24,019,200 | 849,035 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $17,657,984 | 669,624 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $13,924,432 | 458,493 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $7,463,821 | 265,711 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $9,197,474 | 338,890 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $9,530,598 | 310,039 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $10,307,426 | 286,079 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $10,612,858 | 268,544 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $10,419,598 | 259,323 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $6,578,251 | 156,476 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $6,617,083 | 169,843 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,384,428 | 34,741 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $3,249,853 | 89,924 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $51,421,873 | 1,254,498 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $139,073,384 | 3,188,294 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $185,571,986 | 3,707,732 | Shares | Other | 2021-02-01 | |
| 2020-09-30 | $119,515,947 | 2,840,883 | Shares | Other | 2020-11-09 | |
| 2020-06-30 | $157,841,390 | 3,251,110 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||